Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-01-08 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the Shenzhen Huitai Medical Device Co., Ltd. regarding the 2024 first extraordinary shareholders meeting. It details the meeting date, attendance, voting results on various proposals, and legal witness statements. There is no financial data, earnings, or report content, but rather the official voting results and resolutions passed at the shareholders meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4584 characters, which is sufficient to contain detailed voting results rather than a brief announcement. Therefore, the classification is DVA with high confidence.
2024-01-08 Chinese
2024年第一次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the "2024 First Extraordinary General Meeting of Shareholders" of Shenzhen Huitai Medical Devices Co., Ltd. It contains detailed meeting notices, agenda, and multiple proposals to be discussed and voted on during the shareholders meeting. The content includes procedural rules, voting methods, and detailed descriptions of proposals such as related party transactions and use of raised funds. There is no financial statement or earnings data presented, nor is it a transcript or announcement of results. The document is clearly the meeting materials provided to shareholders for the Extraordinary General Meeting (EGM). This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during general meetings (including extraordinary meetings). The document length is substantial and contains detailed meeting agenda and proposals, not just an announcement or notice of a meeting or report publication. Therefore, the correct classification is AGM Information (AGM-R).
2023-12-27 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from the sponsor (中信证券股份有限公司) regarding the use of temporarily idle raised funds by 深圳惠泰医疗器械股份有限公司 for cash management. It references regulatory rules and approvals related to the management and use of raised funds, describes the investment purpose, scope, amount, risk analysis, and the approval process by the board, supervisory committee, and independent directors. The document is not a financial report like an annual or interim report, nor is it a brief announcement or a certification letter. It is a formal verification and audit opinion on a specific financial management activity related to raised funds, which fits the definition of an Audit Report / Information (AR) as it involves audit opinions and compliance verification related to internal controls and regulatory requirements. The document length is 3701 characters, which is substantial and contains detailed content rather than a mere announcement or certification. Therefore, the best classification is AR with high confidence. FY 2023
2023-12-20 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司使用超募资金投资建设新项目的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the use of over-raised funds by Shenzhen Huitai Medical Devices Co., Ltd. for investment in new projects. It includes extensive information on fundraising, project plans, investment amounts, risk analysis, and approvals by the board, supervisory committee, and independent directors. The document references regulatory guidelines and compliance with listing rules, and it is a formal verification and opinion report by the sponsor institution on the use of funds. It is not an announcement of a report publication, nor a brief notice. It contains substantive content related to the use of capital raised, specifically over-raised funds, and the investment projects planned. This fits the category of Capital/Financing Update (CAP), as it deals with updates on company fundraising and capital usage. The document is not a full annual or interim report, nor an earnings release, nor a proxy or voting announcement. Therefore, the appropriate classification is CAP with high confidence.
2023-12-20 Chinese
关于部分募投项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding the postponement of certain fundraising investment projects. It details the original and adjusted timelines for project completion, reasons for the delay, and confirms that the changes do not affect the use of funds or harm shareholders' interests. The document references regulatory approvals and compliance with securities regulations. It is a formal disclosure about changes in the use and timing of previously raised capital, specifically related to fundraising projects. This fits the category of a Capital/Financing Update (CAP), as it provides updates on the company's fundraising investment projects and their timelines. The document length is 3771 characters, which is relatively short but contains substantive information about capital use changes, not merely an announcement of a report publication or a certification. Therefore, the best classification is CAP with high confidence.
2023-12-20 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, roles, responsibilities, nomination, election, and rights of independent directors within the company. The content is focused on internal governance rules and procedures related to board members, specifically independent directors. There is no financial data, no mention of annual or quarterly results, no audit reports, no voting results, no capital changes, no legal proceedings, no merger or acquisition activity, and no investor presentation. The document is a governance-related policy document outlining internal rules and board structure. Therefore, it fits best under the category of Governance Information (CGR). The document length (8121 characters) and detailed content support this classification with high confidence.
2023-12-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.